Ryan focuses his work on patent prosecution matters. By coupling technological acumen with practical legal advice, Ryan works with clients to achieve their business objectives while protecting their intellectual property in the process.

Ryan actively endeavors to understand each client’s larger picture and often bridges the divide between science, law and business. His work includes managing and prosecuting international patent portfolios, drafting patent applications and handling office action responses. Ryan regularly conducts Examiner interviews to advance prosecution of patent applications and conducts due diligence reviews to support merger and acquisition transactions. He also advises on freedom-to-operate, product clearance and patent landscape issues.

His litigation experience includes both patent and trademark matters, from identification of potential infringers to developing exhibits and preparing witnesses for trial.

Prior to joining the firm, Ryan was a research scientist in the agricultural and biotechnology industries. His work included both cell and plant cultures, antibody studies, and protein expression systems. He also served as a judicial extern for the Honorable Mary Pat Thynge, US District Court, District of Delaware.

Award Mouse thought multimedia interface book medal screen monitor
  • Prosecuted patent applications for a large multinational chemical/biotechnology company.
  • Prosecuted patent applications for several biotechnology companies.
  • Supported litigation through trial related to olefin metathesis catalysts.
  • Supported litigation for a multinational company related to polyacrylamide synthesis and manufacturing, working closely with experts.
  • Supported litigation in trademark and trade secret matters.
  • Worked with expert witnesses.


  • Widener University School of Law, J.D., 2016
  • The Johns Hopkins University, M.S., 2010
  • Wesley College, M.B.A., 2008
  • University of Delaware, B.S., 2006


  • Delaware
  • District of Columbia
  • U.S. Patent and Trademark Office

  • Blog, “PTAB Says: Abuse of Process and Improper Use Discovery Is Moot In Denial Of IPR Petition,” PTAB Musings, 2015.
  • Co-Author, Chapter Nine: Pre-Anda Litigation: Strategies and Tactics for Developing a Drug Product and Patent Portfolio, American Bar Association Book Publishing, 2014.

Award Mouse thought multimedia interface book medal screen monitor